VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 709 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $222,727 | +4.0% | 6,564 | -0.8% | 0.04% | -30.8% |
Q1 2023 | $214,085 | -10.1% | 6,618 | -20.3% | 0.05% | -17.5% |
Q4 2022 | $238,116 | +17.3% | 8,308 | -1.5% | 0.06% | -4.5% |
Q3 2022 | $203,000 | -17.8% | 8,434 | +31.2% | 0.07% | -9.6% |
Q1 2022 | $247,000 | -27.4% | 6,428 | -44.4% | 0.07% | -42.5% |
Q3 2021 | $340,000 | -16.0% | 11,552 | -3.0% | 0.13% | -20.1% |
Q2 2021 | $405,000 | -0.2% | 11,908 | -4.7% | 0.16% | -12.6% |
Q1 2021 | $406,000 | +0.5% | 12,494 | +11.3% | 0.18% | -14.6% |
Q4 2020 | $404,000 | -7.6% | 11,228 | +0.6% | 0.21% | -24.5% |
Q3 2020 | $437,000 | +25.2% | 11,157 | +17.3% | 0.28% | +13.7% |
Q2 2020 | $349,000 | – | 9,510 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |